Detalles de la búsqueda
1.
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.
BMC Cancer
; 16: 34, 2016 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26801902
2.
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways.
Tumour Biol
; 36(6): 4327-38, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596703
3.
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
Proc Natl Acad Sci U S A
; 109(16): 6124-9, 2012 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-22454501
4.
TIMP-1 increases expression and phosphorylation of proteins associated with drug resistance in breast cancer cells.
J Proteome Res
; 12(9): 4136-51, 2013 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23909892
5.
TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.
Tumour Biol
; 34(2): 1161-70, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23334956
6.
Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.
Pathol Oncol Res
; 25(1): 59-69, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28963609
7.
Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody.
Sci Rep
; 4: 4313, 2014 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603753
Resultados
1 -
7
de 7
1
Próxima >
>>